Interferon-γ With Donor Leukocyte Infusion

A Phase 2 Trial of Interferon-γ (IFN-γ) in Combination With Donor Leukocyte Infusion (DLI) to Treat Relapsed Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS) After Allogeneic Hematopoietic Stem Cell Transplantation (alloSCT)

More Information

Trial Status
Accepting patients
Trial Phase
Phase 2
Enrollment
45 patients (estimated)
Sponsors
UPMC Hillman Cancer Center
Collaborators
Amgen, Evans MDS Discovery Research Grant
Tags
Donor Lymphocyte Infusion (DLI), Post-Allogeneic Stem Cell Transplant
Trial Type
Treatment
Last Update
2 months ago
SparkCures ID
1974
NCT Identifier
NCT06529731

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print this trial to share with your doctor.

We can help answer any questions and connect you (or your patient) with the study team.

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.